hgfs Search Results


95
CLS Cell Lines Service GmbH cell lines hdpscs human dental pulp stem cells 300 702 and hgfs human gingival fibroblasts 300 703
Cell Lines Hdpscs Human Dental Pulp Stem Cells 300 702 And Hgfs Human Gingival Fibroblasts 300 703, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cell lines hdpscs human dental pulp stem cells 300 702 and hgfs human gingival fibroblasts 300 703/product/CLS Cell Lines Service GmbH
Average 95 stars, based on 1 article reviews
cell lines hdpscs human dental pulp stem cells 300 702 and hgfs human gingival fibroblasts 300 703 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

92
Innoprot Inc human gingival fibroblast cell vials
Human Gingival Fibroblast Cell Vials, supplied by Innoprot Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human gingival fibroblast cell vials/product/Innoprot Inc
Average 92 stars, based on 1 article reviews
human gingival fibroblast cell vials - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

90
AcceGen Biotechnology human gingival fibroblasts
Effects of ASTX on ROS levels induced by hyperglycemia in human gingival <t>fibroblasts</t> were determined by confocal microscopy. Representative images of DCFDA from 5-, 25-, and 50 mM glucose and ASTX-treated groups are given. To monitor the ROS levels, DCFDA loaded cells were calibrated with 100 μ M H 2 O 2 . Changes in total fluorescent intensity in LG group were higher than HG groups, as well as ASTX-treated group ( p < 0.001). ROS levels were decreased in the ASTX group when compared to the 50 mM HG group ( p < 0.001). Scale bar: 80 μ m.
Human Gingival Fibroblasts, supplied by AcceGen Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human gingival fibroblasts/product/AcceGen Biotechnology
Average 90 stars, based on 1 article reviews
human gingival fibroblasts - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

93
Innoprot Inc human gingival fibroblasts
Effects of ASTX on ROS levels induced by hyperglycemia in human gingival <t>fibroblasts</t> were determined by confocal microscopy. Representative images of DCFDA from 5-, 25-, and 50 mM glucose and ASTX-treated groups are given. To monitor the ROS levels, DCFDA loaded cells were calibrated with 100 μ M H 2 O 2 . Changes in total fluorescent intensity in LG group were higher than HG groups, as well as ASTX-treated group ( p < 0.001). ROS levels were decreased in the ASTX group when compared to the 50 mM HG group ( p < 0.001). Scale bar: 80 μ m.
Human Gingival Fibroblasts, supplied by Innoprot Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human gingival fibroblasts/product/Innoprot Inc
Average 93 stars, based on 1 article reviews
human gingival fibroblasts - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

90
ScienCell primary hgfs
miR-200c protects LPS-induced ABL in rat <t>periodontitis.</t> Rats were injected bi-weekly with 10 μg LPS and treated weekly with one injection of PBS, PEI facilitating EV (1 and 10 μg), miR-200c (1 and 10 μg) up to 4 weeks. (A) Three-dimensional reconstructed micro-computed tomography images of maxillary alveolar bone on the palatal sides of rats 4 weeks after receiving an LPS injection with and without miR-200c. Red dot lines indicate the ABC and CEJ at maxillary second molars. Scale bars: 1 mm. (B, C) The outcome of the ABL (B) and the inter-radicular space (C) at the M2 after 4 weeks. (D, E) Structural parameters of alveolar bone 4 weeks after different treatment, including (Tb. Th) (D), and the percentages of BV/TV, BS/BV, and the total alveolar bone porosity (E). *P < 0.05 versus untreated; #P < 0.05 versus LPS-PBS; n = 8 for each treatment. ABC, alveolar bone crest; ABL, alveolar bone loss; BS, bone surface; BV, bone volume; CEJ, cemento-enamel junction; M2, second maxillary molar; PBS, phosphate-buffered saline; Tb. Th, trabecular thickness; TV, tissue volume. Color images are available online.
Primary Hgfs, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary hgfs/product/ScienCell
Average 90 stars, based on 1 article reviews
primary hgfs - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
ScienCell hgfs
miR-200c protects LPS-induced ABL in rat <t>periodontitis.</t> Rats were injected bi-weekly with 10 μg LPS and treated weekly with one injection of PBS, PEI facilitating EV (1 and 10 μg), miR-200c (1 and 10 μg) up to 4 weeks. (A) Three-dimensional reconstructed micro-computed tomography images of maxillary alveolar bone on the palatal sides of rats 4 weeks after receiving an LPS injection with and without miR-200c. Red dot lines indicate the ABC and CEJ at maxillary second molars. Scale bars: 1 mm. (B, C) The outcome of the ABL (B) and the inter-radicular space (C) at the M2 after 4 weeks. (D, E) Structural parameters of alveolar bone 4 weeks after different treatment, including (Tb. Th) (D), and the percentages of BV/TV, BS/BV, and the total alveolar bone porosity (E). *P < 0.05 versus untreated; #P < 0.05 versus LPS-PBS; n = 8 for each treatment. ABC, alveolar bone crest; ABL, alveolar bone loss; BS, bone surface; BV, bone volume; CEJ, cemento-enamel junction; M2, second maxillary molar; PBS, phosphate-buffered saline; Tb. Th, trabecular thickness; TV, tissue volume. Color images are available online.
Hgfs, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hgfs/product/ScienCell
Average 90 stars, based on 1 article reviews
hgfs - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Elabscience Biotechnology human gingival fibroblasts (hgfs)
miR-200c protects LPS-induced ABL in rat <t>periodontitis.</t> Rats were injected bi-weekly with 10 μg LPS and treated weekly with one injection of PBS, PEI facilitating EV (1 and 10 μg), miR-200c (1 and 10 μg) up to 4 weeks. (A) Three-dimensional reconstructed micro-computed tomography images of maxillary alveolar bone on the palatal sides of rats 4 weeks after receiving an LPS injection with and without miR-200c. Red dot lines indicate the ABC and CEJ at maxillary second molars. Scale bars: 1 mm. (B, C) The outcome of the ABL (B) and the inter-radicular space (C) at the M2 after 4 weeks. (D, E) Structural parameters of alveolar bone 4 weeks after different treatment, including (Tb. Th) (D), and the percentages of BV/TV, BS/BV, and the total alveolar bone porosity (E). *P < 0.05 versus untreated; #P < 0.05 versus LPS-PBS; n = 8 for each treatment. ABC, alveolar bone crest; ABL, alveolar bone loss; BS, bone surface; BV, bone volume; CEJ, cemento-enamel junction; M2, second maxillary molar; PBS, phosphate-buffered saline; Tb. Th, trabecular thickness; TV, tissue volume. Color images are available online.
Human Gingival Fibroblasts (Hgfs), supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human gingival fibroblasts (hgfs)/product/Elabscience Biotechnology
Average 90 stars, based on 1 article reviews
human gingival fibroblasts (hgfs) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Lifeline Cell Technology hgfs
miR-200c protects LPS-induced ABL in rat <t>periodontitis.</t> Rats were injected bi-weekly with 10 μg LPS and treated weekly with one injection of PBS, PEI facilitating EV (1 and 10 μg), miR-200c (1 and 10 μg) up to 4 weeks. (A) Three-dimensional reconstructed micro-computed tomography images of maxillary alveolar bone on the palatal sides of rats 4 weeks after receiving an LPS injection with and without miR-200c. Red dot lines indicate the ABC and CEJ at maxillary second molars. Scale bars: 1 mm. (B, C) The outcome of the ABL (B) and the inter-radicular space (C) at the M2 after 4 weeks. (D, E) Structural parameters of alveolar bone 4 weeks after different treatment, including (Tb. Th) (D), and the percentages of BV/TV, BS/BV, and the total alveolar bone porosity (E). *P < 0.05 versus untreated; #P < 0.05 versus LPS-PBS; n = 8 for each treatment. ABC, alveolar bone crest; ABL, alveolar bone loss; BS, bone surface; BV, bone volume; CEJ, cemento-enamel junction; M2, second maxillary molar; PBS, phosphate-buffered saline; Tb. Th, trabecular thickness; TV, tissue volume. Color images are available online.
Hgfs, supplied by Lifeline Cell Technology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hgfs/product/Lifeline Cell Technology
Average 90 stars, based on 1 article reviews
hgfs - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Procell Inc hgfs
miR-200c protects LPS-induced ABL in rat <t>periodontitis.</t> Rats were injected bi-weekly with 10 μg LPS and treated weekly with one injection of PBS, PEI facilitating EV (1 and 10 μg), miR-200c (1 and 10 μg) up to 4 weeks. (A) Three-dimensional reconstructed micro-computed tomography images of maxillary alveolar bone on the palatal sides of rats 4 weeks after receiving an LPS injection with and without miR-200c. Red dot lines indicate the ABC and CEJ at maxillary second molars. Scale bars: 1 mm. (B, C) The outcome of the ABL (B) and the inter-radicular space (C) at the M2 after 4 weeks. (D, E) Structural parameters of alveolar bone 4 weeks after different treatment, including (Tb. Th) (D), and the percentages of BV/TV, BS/BV, and the total alveolar bone porosity (E). *P < 0.05 versus untreated; #P < 0.05 versus LPS-PBS; n = 8 for each treatment. ABC, alveolar bone crest; ABL, alveolar bone loss; BS, bone surface; BV, bone volume; CEJ, cemento-enamel junction; M2, second maxillary molar; PBS, phosphate-buffered saline; Tb. Th, trabecular thickness; TV, tissue volume. Color images are available online.
Hgfs, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hgfs/product/Procell Inc
Average 90 stars, based on 1 article reviews
hgfs - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
PROVITRO GmbH hgfs
miR-200c protects LPS-induced ABL in rat <t>periodontitis.</t> Rats were injected bi-weekly with 10 μg LPS and treated weekly with one injection of PBS, PEI facilitating EV (1 and 10 μg), miR-200c (1 and 10 μg) up to 4 weeks. (A) Three-dimensional reconstructed micro-computed tomography images of maxillary alveolar bone on the palatal sides of rats 4 weeks after receiving an LPS injection with and without miR-200c. Red dot lines indicate the ABC and CEJ at maxillary second molars. Scale bars: 1 mm. (B, C) The outcome of the ABL (B) and the inter-radicular space (C) at the M2 after 4 weeks. (D, E) Structural parameters of alveolar bone 4 weeks after different treatment, including (Tb. Th) (D), and the percentages of BV/TV, BS/BV, and the total alveolar bone porosity (E). *P < 0.05 versus untreated; #P < 0.05 versus LPS-PBS; n = 8 for each treatment. ABC, alveolar bone crest; ABL, alveolar bone loss; BS, bone surface; BV, bone volume; CEJ, cemento-enamel junction; M2, second maxillary molar; PBS, phosphate-buffered saline; Tb. Th, trabecular thickness; TV, tissue volume. Color images are available online.
Hgfs, supplied by PROVITRO GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hgfs/product/PROVITRO GmbH
Average 90 stars, based on 1 article reviews
hgfs - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Primary Cell Co Ltd hgfs
miR-200c protects LPS-induced ABL in rat <t>periodontitis.</t> Rats were injected bi-weekly with 10 μg LPS and treated weekly with one injection of PBS, PEI facilitating EV (1 and 10 μg), miR-200c (1 and 10 μg) up to 4 weeks. (A) Three-dimensional reconstructed micro-computed tomography images of maxillary alveolar bone on the palatal sides of rats 4 weeks after receiving an LPS injection with and without miR-200c. Red dot lines indicate the ABC and CEJ at maxillary second molars. Scale bars: 1 mm. (B, C) The outcome of the ABL (B) and the inter-radicular space (C) at the M2 after 4 weeks. (D, E) Structural parameters of alveolar bone 4 weeks after different treatment, including (Tb. Th) (D), and the percentages of BV/TV, BS/BV, and the total alveolar bone porosity (E). *P < 0.05 versus untreated; #P < 0.05 versus LPS-PBS; n = 8 for each treatment. ABC, alveolar bone crest; ABL, alveolar bone loss; BS, bone surface; BV, bone volume; CEJ, cemento-enamel junction; M2, second maxillary molar; PBS, phosphate-buffered saline; Tb. Th, trabecular thickness; TV, tissue volume. Color images are available online.
Hgfs, supplied by Primary Cell Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hgfs/product/Primary Cell Co Ltd
Average 90 stars, based on 1 article reviews
hgfs - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Keygen Biotech elisa kits of hgfs
miR-200c protects LPS-induced ABL in rat <t>periodontitis.</t> Rats were injected bi-weekly with 10 μg LPS and treated weekly with one injection of PBS, PEI facilitating EV (1 and 10 μg), miR-200c (1 and 10 μg) up to 4 weeks. (A) Three-dimensional reconstructed micro-computed tomography images of maxillary alveolar bone on the palatal sides of rats 4 weeks after receiving an LPS injection with and without miR-200c. Red dot lines indicate the ABC and CEJ at maxillary second molars. Scale bars: 1 mm. (B, C) The outcome of the ABL (B) and the inter-radicular space (C) at the M2 after 4 weeks. (D, E) Structural parameters of alveolar bone 4 weeks after different treatment, including (Tb. Th) (D), and the percentages of BV/TV, BS/BV, and the total alveolar bone porosity (E). *P < 0.05 versus untreated; #P < 0.05 versus LPS-PBS; n = 8 for each treatment. ABC, alveolar bone crest; ABL, alveolar bone loss; BS, bone surface; BV, bone volume; CEJ, cemento-enamel junction; M2, second maxillary molar; PBS, phosphate-buffered saline; Tb. Th, trabecular thickness; TV, tissue volume. Color images are available online.
Elisa Kits Of Hgfs, supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elisa kits of hgfs/product/Keygen Biotech
Average 90 stars, based on 1 article reviews
elisa kits of hgfs - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Effects of ASTX on ROS levels induced by hyperglycemia in human gingival fibroblasts were determined by confocal microscopy. Representative images of DCFDA from 5-, 25-, and 50 mM glucose and ASTX-treated groups are given. To monitor the ROS levels, DCFDA loaded cells were calibrated with 100 μ M H 2 O 2 . Changes in total fluorescent intensity in LG group were higher than HG groups, as well as ASTX-treated group ( p < 0.001). ROS levels were decreased in the ASTX group when compared to the 50 mM HG group ( p < 0.001). Scale bar: 80 μ m.

Journal: BioMed Research International

Article Title: Astaxanthin Enhances Gingival Wound Healing following High Glucose-Induced Oxidative Stress

doi: 10.1155/2022/4043105

Figure Lengend Snippet: Effects of ASTX on ROS levels induced by hyperglycemia in human gingival fibroblasts were determined by confocal microscopy. Representative images of DCFDA from 5-, 25-, and 50 mM glucose and ASTX-treated groups are given. To monitor the ROS levels, DCFDA loaded cells were calibrated with 100 μ M H 2 O 2 . Changes in total fluorescent intensity in LG group were higher than HG groups, as well as ASTX-treated group ( p < 0.001). ROS levels were decreased in the ASTX group when compared to the 50 mM HG group ( p < 0.001). Scale bar: 80 μ m.

Article Snippet: Human gingival fibroblasts (Accegen Biotechnology, Fairfield, New Jersey, USA, Cat no: ABC-TC3627) were incubated in low glucose (LG) conditions; in a 1 : 1 mixture of Dulbecco's Modified Eagle's Medium/Nutrient Mixture Ham's F-12 (DMEM/F12) containing 10% heat-inactivated fetal bovine serum (FBS), 100 U/ml- μ g/ml penicillin-streptomycin (PS), and 2.5 mg/ml amphotericin B (AMP-B) in a humidified atmosphere of 5% CO 2 at 37°C.

Techniques: Confocal Microscopy

miR-200c protects LPS-induced ABL in rat periodontitis. Rats were injected bi-weekly with 10 μg LPS and treated weekly with one injection of PBS, PEI facilitating EV (1 and 10 μg), miR-200c (1 and 10 μg) up to 4 weeks. (A) Three-dimensional reconstructed micro-computed tomography images of maxillary alveolar bone on the palatal sides of rats 4 weeks after receiving an LPS injection with and without miR-200c. Red dot lines indicate the ABC and CEJ at maxillary second molars. Scale bars: 1 mm. (B, C) The outcome of the ABL (B) and the inter-radicular space (C) at the M2 after 4 weeks. (D, E) Structural parameters of alveolar bone 4 weeks after different treatment, including (Tb. Th) (D), and the percentages of BV/TV, BS/BV, and the total alveolar bone porosity (E). *P < 0.05 versus untreated; #P < 0.05 versus LPS-PBS; n = 8 for each treatment. ABC, alveolar bone crest; ABL, alveolar bone loss; BS, bone surface; BV, bone volume; CEJ, cemento-enamel junction; M2, second maxillary molar; PBS, phosphate-buffered saline; Tb. Th, trabecular thickness; TV, tissue volume. Color images are available online.

Journal: Stem Cells and Development

Article Title: MicroRNA-200c Attenuates Periodontitis by Modulating Proinflammatory and Osteoclastogenic Mediators

doi: 10.1089/scd.2019.0027

Figure Lengend Snippet: miR-200c protects LPS-induced ABL in rat periodontitis. Rats were injected bi-weekly with 10 μg LPS and treated weekly with one injection of PBS, PEI facilitating EV (1 and 10 μg), miR-200c (1 and 10 μg) up to 4 weeks. (A) Three-dimensional reconstructed micro-computed tomography images of maxillary alveolar bone on the palatal sides of rats 4 weeks after receiving an LPS injection with and without miR-200c. Red dot lines indicate the ABC and CEJ at maxillary second molars. Scale bars: 1 mm. (B, C) The outcome of the ABL (B) and the inter-radicular space (C) at the M2 after 4 weeks. (D, E) Structural parameters of alveolar bone 4 weeks after different treatment, including (Tb. Th) (D), and the percentages of BV/TV, BS/BV, and the total alveolar bone porosity (E). *P < 0.05 versus untreated; #P < 0.05 versus LPS-PBS; n = 8 for each treatment. ABC, alveolar bone crest; ABL, alveolar bone loss; BS, bone surface; BV, bone volume; CEJ, cemento-enamel junction; M2, second maxillary molar; PBS, phosphate-buffered saline; Tb. Th, trabecular thickness; TV, tissue volume. Color images are available online.

Article Snippet: As the resident cells in periodontitis, primary HGFs (Sciencell, Carlsbad, CA) were used to test the inhibitory function of miR-200c in proinflammatory and osteoclastogenic mediators.

Techniques: Injection, Micro-CT, Saline

Histological analysis of alveolar bone and periodontal ligament adjacent to the M2 of 4 weeks LPS-treated rats. (A) and (B) Representative micrographs of sham and periodontitis rats treated with PBS, PEI facilitating EV (1 and 10 μg), and miR-200c (1 and 10 μg) with hematoxylin and eosin staining (A) and Masson's trichrome staining (B). Magnification = 4. (C) Ratio of the remaining ACB to the RL adjacent to the M2. The ratio of the ACB to the RL was calculated by using the formula (ABC-RA)/(CEJ-RA), where ABC-RA is the distance from ABC to RA and CEJ-RA is the distance from CEJ to RA. *P < 0.05 vs untreated; #P < 0.05 versus LPS-PBS; n = 3 for each treatment. ACB, alveolar crest bone; RA, root apex; RL, root length. Color images are available online.

Journal: Stem Cells and Development

Article Title: MicroRNA-200c Attenuates Periodontitis by Modulating Proinflammatory and Osteoclastogenic Mediators

doi: 10.1089/scd.2019.0027

Figure Lengend Snippet: Histological analysis of alveolar bone and periodontal ligament adjacent to the M2 of 4 weeks LPS-treated rats. (A) and (B) Representative micrographs of sham and periodontitis rats treated with PBS, PEI facilitating EV (1 and 10 μg), and miR-200c (1 and 10 μg) with hematoxylin and eosin staining (A) and Masson's trichrome staining (B). Magnification = 4. (C) Ratio of the remaining ACB to the RL adjacent to the M2. The ratio of the ACB to the RL was calculated by using the formula (ABC-RA)/(CEJ-RA), where ABC-RA is the distance from ABC to RA and CEJ-RA is the distance from CEJ to RA. *P < 0.05 vs untreated; #P < 0.05 versus LPS-PBS; n = 3 for each treatment. ACB, alveolar crest bone; RA, root apex; RL, root length. Color images are available online.

Article Snippet: As the resident cells in periodontitis, primary HGFs (Sciencell, Carlsbad, CA) were used to test the inhibitory function of miR-200c in proinflammatory and osteoclastogenic mediators.

Techniques: Staining

Potential mechanism(s) of anti-inflammatory/osteoclastogenic function of miR-200c to attenuate periodontitis.

Journal: Stem Cells and Development

Article Title: MicroRNA-200c Attenuates Periodontitis by Modulating Proinflammatory and Osteoclastogenic Mediators

doi: 10.1089/scd.2019.0027

Figure Lengend Snippet: Potential mechanism(s) of anti-inflammatory/osteoclastogenic function of miR-200c to attenuate periodontitis.

Article Snippet: As the resident cells in periodontitis, primary HGFs (Sciencell, Carlsbad, CA) were used to test the inhibitory function of miR-200c in proinflammatory and osteoclastogenic mediators.

Techniques: